drugset / Trial / NCT04468542
Randomized Placebo-controlled Analysis of Superior Laryngeal Nerve Block for Neurogenic Cough
RandomizedParallel-groupSingle-blindTreatment
Summary
Prospective randomized placebo-controlled trial assessing the efficacy of superior laryngeal nerve block for adults with neurogenic cough refractory to proton pump inhibitor as determined by improvement in validated cough severity questionnaires before and after injection of Marcaine and Kenalog compared to placebo (saline injection).
Timeline
- Start
- 2021-01-12
- Primary completion
- 2022-12
- Completion
- 2022-12
Publications
- Background Simpson CB, Tibbetts KM, Loochtan MJ, Dominguez LM. Treatment of chronic neurogenic cough with in-office superior laryngeal nerve block. Laryngoscope. 2018 Aug;128(8):1898-1903. doi: 10.1002/lary.27201. Epub 2018 Apr 18.
- Background Dhillon VK. Superior laryngeal nerve block for neurogenic cough: A case series. Laryngoscope Investig Otolaryngol. 2019 Jul 5;4(4):410-413. doi: 10.1002/lio2.292. eCollection 2019 Aug.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.5 % | Other |
| Subject | Triamcinolone Acetonide | Other / unclassified | 40 mg/ml | Other |
Indications
No indication recorded.